Rapport Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $19k | 941 | 20.48 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors